Overview
Top Medical Research Studies
We observed that the long-term use of this treatment system significantly reduced the risk of pneumonia recurrence. It also appeared to help prevent the emergence of certain cancers in older patients suffering from interstitial pneumonia. Surprisingly, we found a link between interstitial pneumonia and an increased risk of depression, likely driven by prolonged glucocorticoid use.
While some patients showed promise under this treatment, those battling both interstitial pneumonia and depression responded less favorably. We suggested that increasing the amount of dehydroepiandrosterone in the treatment could be beneficial. Throughout our experience, we noted that the characteristics of chronic fatigue syndrome align closely with those of interstitial pneumonia, arguing against the notion that they should be viewed as separate conditions.
Overall, our approach not only alleviated inflammation but did not suppress the fibrotic processes in the long run. We made modifications to the treatment to lower the risks of vascular complications. The main strength of our treatment lies in creating a hormonal environment that helps tackle immune deficiencies using vitamin C, which faces lower resistance in the body compared to steroid treatments.
Our analysis revealed that a significant portion of patients experienced symptoms aligning with CFS, characterized by a prolonged illness that required extensive medical care. Patients tended to respond better to a combination of both the old and new vitamin C infusions rather than relying solely on the traditional treatment.
Notably, the combined treatment was more effective, suggesting that there may be underlying issues related to hormone levels in CFS patients that are influenced by vitamin C therapy. However, we also noted potential side effects with the sole use of the new vitamin C infusion. A careful balance between the different infusion approaches is crucial for achieving the best outcomes in CFS management.
Overall, while we observed some promising responses to vitamin C treatments, more research is necessary to fully understand its effectiveness and to optimize treatment strategies for those suffering from chronic fatigue syndrome.
What we found is quite promising. High doses of vitamin C appeared to reduce the duration of disease symptoms and helped decrease antibody levels associated with EBV. Notably, we observed that patients with higher levels of vitamin C in their plasma generally had lower levels of certain EBV antibodies, suggesting a potential link that might help manage symptoms of CFS.
Furthermore, there was an interesting connection between vitamin D levels and EBV antibodies as well. Patients who had high levels of vitamin D showed lower levels of EBV early antigen antibodies. This points towards a holistic approach to managing CFS, where both vitamin C and vitamin D may play beneficial roles. Overall, our findings hint at an encouraging effect of high dose vitamin C therapy in helping those grappling with CFS due to EBV.
Most Useful Reviews
Medical Researches
- All Researches
What we found is quite promising. High doses of vitamin C appeared to reduce the duration of disease symptoms and helped decrease antibody levels associated with EBV. Notably, we observed that patients with higher levels of vitamin C in their plasma generally had lower levels of certain EBV antibodies, suggesting a potential link that might help manage symptoms of CFS.
Furthermore, there was an interesting connection between vitamin D levels and EBV antibodies as well. Patients who had high levels of vitamin D showed lower levels of EBV early antigen antibodies. This points towards a holistic approach to managing CFS, where both vitamin C and vitamin D may play beneficial roles. Overall, our findings hint at an encouraging effect of high dose vitamin C therapy in helping those grappling with CFS due to EBV.
Initially, the old infusion method, alongside some antibiotics, showed effectiveness in managing the patient’s pneumonia, which was a part of the CFS symptoms. However, over time, pneumonia symptoms returned, prompting us to alternate between the old and new vitamin C treatments along with longer antibiotic use. Remarkably, this switch led to a notable reduction in pneumonia signs.
We found that the new vitamin C infusion treatment dramatically increased urine excretion of certain hormones, suggesting an enhancement of the body’s steroid activities. Notably, some evidence indicated that the dehydroepiandrosterone was converted into testosterone, which could positively influence the CFS control. However, our searches for changes in immune response didn’t yield significant results.
Ultimately, our observations suggest that the new vitamin C treatment could help manage CFS by boosting cortisol and testosterone levels, but additional studies would be necessary to fully understand its effectiveness in isolation.
We observed that the long-term use of this treatment system significantly reduced the risk of pneumonia recurrence. It also appeared to help prevent the emergence of certain cancers in older patients suffering from interstitial pneumonia. Surprisingly, we found a link between interstitial pneumonia and an increased risk of depression, likely driven by prolonged glucocorticoid use.
While some patients showed promise under this treatment, those battling both interstitial pneumonia and depression responded less favorably. We suggested that increasing the amount of dehydroepiandrosterone in the treatment could be beneficial. Throughout our experience, we noted that the characteristics of chronic fatigue syndrome align closely with those of interstitial pneumonia, arguing against the notion that they should be viewed as separate conditions.
Overall, our approach not only alleviated inflammation but did not suppress the fibrotic processes in the long run. We made modifications to the treatment to lower the risks of vascular complications. The main strength of our treatment lies in creating a hormonal environment that helps tackle immune deficiencies using vitamin C, which faces lower resistance in the body compared to steroid treatments.
Our analysis revealed that a significant portion of patients experienced symptoms aligning with CFS, characterized by a prolonged illness that required extensive medical care. Patients tended to respond better to a combination of both the old and new vitamin C infusions rather than relying solely on the traditional treatment.
Notably, the combined treatment was more effective, suggesting that there may be underlying issues related to hormone levels in CFS patients that are influenced by vitamin C therapy. However, we also noted potential side effects with the sole use of the new vitamin C infusion. A careful balance between the different infusion approaches is crucial for achieving the best outcomes in CFS management.
Overall, while we observed some promising responses to vitamin C treatments, more research is necessary to fully understand its effectiveness and to optimize treatment strategies for those suffering from chronic fatigue syndrome.
However, our findings highlight four key issues. First, it is still debated whether these treatments should continue on a maintenance basis when no acute symptoms are present. Some evidence suggests their ongoing use is crucial for halting an evolving bacterial colony in patients with immune deficiencies.
Second, we noted an emerging problem with drug-resistant bacteria, which posed challenges in treatment effectiveness. New antibiotics, like kanamycin, showed promise in addressing this resistance and improving pneumonia symptoms.
Third, we observed a decline in bone marrow function in one patient over a nine-year observation period, indicating potential fibrosis similar to that seen in lung tissue.
Lastly, we encountered a case where a female patient developed breast cancer during treatment, raising concerns about the risks of prolonged autoimmune conditions in older adults. Interestingly, dehydroepiandrosterone appeared to support hepatic recovery during cancer chemotherapy, suggesting complex interactions between treatments and patient responses.
Overall, while vitamin C plays a role in the treatment approach, the complexities of chronic fatigue syndrome and interstitial pneumonia present challenges that require further investigation.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), is a complex and debilitating condition characterized by profound fatigue that doesn’t improve with rest and worsens with physical or mental activity. This crippling fatigue is often accompanied by a variety of symptoms, including sleep disturbances, cognitive difficulties, muscle pain, and joint pain. Unlike typical tiredness, the fatigue experienced in CFS is long-lasting, and it can significantly hinder everyday activities and overall quality of life.
The precise cause of CFS remains unknown, but it is believed to be influenced by a combination of genetic, environmental, immunological, and psychological factors. Diagnosis primarily relies on a careful assessment of symptoms, as there are no definitive laboratory tests available. Treatment options focus on symptom management and may include lifestyle changes, physical therapy, medication for pain management, and cognitive behavioral therapy. Given the complexity and variability of the condition, individuals with CFS should consult healthcare professionals who specialize in this area to develop personalized management strategies.
Vitamin C, also known as ascorbic acid, is a water-soluble vitamin that plays a critical role in numerous bodily functions. As an essential nutrient, it contributes to the growth and repair of tissues in the body, and it is vital for the production of collagen, an important protein that helps maintain skin, cartilage, tendons, ligaments, and blood vessels. Additionally, Vitamin C acts as a powerful antioxidant, which means it helps combat free radicals—unstable molecules that can cause oxidative stress and contribute to various chronic diseases.
Moreover, Vitamin C enhances iron absorption from plant-based foods, making it a vital component for those following vegetarian or vegan diets. While many people get sufficient Vitamin C from a well-balanced diet that includes fruits and vegetables like oranges, strawberries, kiwi, broccoli, and bell peppers, some individuals might require supplementation. It's generally recommended to stay within the daily intake guidelines, as excessive consumption can lead to gastrointestinal disturbances. Overall, Vitamin C is not just a skincare celebrity—it's a fundamental part of maintaining overall health and well-being.
Chronic Fatigue Syndrome (CFS) is a complex condition characterized by extreme fatigue that doesn't improve with rest and can worsen with physical or mental exertion. While vitamin C is well-known for its role in supporting the immune system and combating oxidative stress, there's limited research specifically addressing its efficacy in treating CFS. Some studies suggest that vitamin C may help alleviate certain symptoms of fatigue due to its antioxidant properties, which could help reduce inflammation and promote overall wellbeing. However, it is essential to note that vitamin C should not be seen as a cure for CFS.
If you are considering vitamin C supplementation as part of your management strategy for CFS, it’s crucial to consult with a healthcare professional. They can provide personalized advice based on your individual health needs and circumstances. Additionally, it's beneficial to adopt a holistic approach that may include proper nutrition, adequate rest, and perhaps other therapies geared towards managing CFS symptoms. Ultimately, while vitamin C may offer some benefits, it's not a definitive solution for everyone suffering from Chronic Fatigue Syndrome.
Based on user reviews, the time it takes to see results from taking vitamin C for Chronic Fatigue Syndrome can vary. Many users report improvements quite quickly, with some noticing a significant decrease in fatigue and lethargy almost immediately after starting the supplement. For instance, one reviewer mentioned a noticeable reduction in fatigue within the first few days of use, stating, "I felt a shift as soon as I started taking it daily!" (Read Review)
However, other users have indicated that it may take longer to experience the full benefits, suggesting around one to two months for more substantial improvements. A reviewer highlighted that after two months of use, they had reduced their dose and experienced a big difference, enhancing their energy levels significantly while managing chronic fatigue syndrome (Read Review). Overall, you may see some initial results within the first week, but keep in mind that consistent use over time may yield the best outcomes.
The role of vitamin C as a treatment for Chronic Fatigue Syndrome (CFS) has gathered some intriguing scientific backing, particularly in studies focusing on its potential benefits. Research indicates that high-dose intravenous vitamin C may help alleviate symptoms in patients with CFS linked to Epstein-Barr virus (EBV) infections. A study involving 178 patients suggested that vitamin C not only seemed to reduce the duration of symptoms but also lowered specific EBV antibody levels in those with higher plasma vitamin C concentrations [1]. Similarly, findings from additional studies indicate that vitamin C treatments can lead to improved outcomes in patients struggling with complications like interstitial pneumonia, which is often associated with CFS [3].
While these findings are encouraging, it’s clear that the complexities of CFS demand more research to establish standardized treatment protocols. Some studies indicate that combining vitamin C with other treatments, like dehydroepiandrosterone, may yield better results than vitamin C alone [4]. However, concerns about the long-term use of these treatments, as well as potential side effects, highlight the need for careful management and more extensive investigations [2]. Overall, while the evidence leans positively towards vitamin C, definitive conclusions about its effectiveness for CFS require further rigorous studies.
Users have reported various improvements in their symptoms after incorporating vitamin C into their routines, particularly those dealing with chronic fatigue syndrome. Many individuals express noticeable enhancements in energy levels and reductions in fatigue, with several stating that they felt a significant shift shortly after starting the supplement. For example, one user claimed, "I felt a shift as soon as I started taking it daily!" indicating a quick response from the body (Read Review). Others mentioned longer-term benefits, noting enhanced energy and reduced lethargy after a couple of months of consistent use (Read Review).
Additionally, users highlight that vitamin C has not only helped in managing their chronic fatigue syndrome but also improved their overall well-being. There are testimonials of decreased feelings of withdrawal, better immune support, and improved skin health attributed to the antioxidant properties of vitamin C (Read Review). While experiences can vary, many users agree that incorporating this vitamin has been a game-changer for their daily lives, allowing them to combat fatigue and improve their general health.
Users have shared their experiences regarding the combination of vitamin C with other supplements for managing Chronic Fatigue Syndrome (CFS). Several reviewers highlighted the benefits of taking vitamin C alongside bioflavonoids, stating that this combination amplifies the antioxidant effects and overall vitality. For example, one user mentioned that the inclusion of bioflavonoids enhanced the effectiveness of the supplement in managing withdrawal symptoms and improving adrenal fatigue (Read Review). Others have noted that integrating vitamin C into a larger regimen, such as taking one pill three times daily along with other vitamins, has resulted in faster recovery from fatigue, particularly during challenging seasons (Read Review).
Moreover, users report improved energy levels and reduced fatigue when using vitamin C in combination with other dietary approaches, including meal timing strategies. For instance, one user found that taking vitamin C after meals aided in managing fatigue while also addressing dieting goals (Read Review). Overall, the feedback suggests that supplementing vitamin C, especially in conjunction with other vitamins or adjustments to diet and meal timing, can be beneficial for individuals grappling with Chronic Fatigue Syndrome.
Users report varying doses of Vitamin C for managing Chronic Fatigue Syndrome, with most finding significant benefits from higher amounts. One user mentions taking 5 grams daily in divided doses for improved adrenal fatigue and withdrawal symptoms from benzodiazepines (Read Review). Other users share experiences of taking multiple capsules, with one individual consuming six pills daily, divided across meals, noting a reduction in fatigue and improved blood vessel health (Read Review). Additionally, another user follows a regimen of one pill three times daily, reporting faster recovery from fatigue, which is crucial for managing their chronic fatigue symptoms (Read Review).
The general consensus among users indicates that a higher intake of Vitamin C, often in divided doses, tends to yield better results in alleviating symptoms of Chronic Fatigue Syndrome. Many users have also noted that this supplementation significantly enhances their energy levels and reduces lethargy, contributing positively to their overall wellbeing (Read Review), (Read Review). As such, those considering Vitamin C should consult with healthcare professionals to determine the appropriate dosage tailored to their needs.
What we found is quite promising. High doses of vitamin C appeared to reduce the duration of disease symptoms and helped decrease antibody levels associated with EBV. Notably, we observed that patients with higher levels of vitamin C in their plasma generally had lower levels of certain EBV antibodies, suggesting a potential link that might help manage symptoms of CFS.
Furthermore, there was an interesting connection between vitamin D levels and EBV antibodies as well. Patients who had high levels of vitamin D showed lower levels of EBV early antigen antibodies. This points towards a holistic approach to managing CFS, where both vitamin C and vitamin D may play beneficial roles. Overall, our findings hint at an encouraging effect of high dose vitamin C therapy in helping those grappling with CFS due to EBV.
We observed that the long-term use of this treatment system significantly reduced the risk of pneumonia recurrence. It also appeared to help prevent the emergence of certain cancers in older patients suffering from interstitial pneumonia. Surprisingly, we found a link between interstitial pneumonia and an increased risk of depression, likely driven by prolonged glucocorticoid use.
While some patients showed promise under this treatment, those battling both interstitial pneumonia and depression responded less favorably. We suggested that increasing the amount of dehydroepiandrosterone in the treatment could be beneficial. Throughout our experience, we noted that the characteristics of chronic fatigue syndrome align closely with those of interstitial pneumonia, arguing against the notion that they should be viewed as separate conditions.
Overall, our approach not only alleviated inflammation but did not suppress the fibrotic processes in the long run. We made modifications to the treatment to lower the risks of vascular complications. The main strength of our treatment lies in creating a hormonal environment that helps tackle immune deficiencies using vitamin C, which faces lower resistance in the body compared to steroid treatments.
Our analysis revealed that a significant portion of patients experienced symptoms aligning with CFS, characterized by a prolonged illness that required extensive medical care. Patients tended to respond better to a combination of both the old and new vitamin C infusions rather than relying solely on the traditional treatment.
Notably, the combined treatment was more effective, suggesting that there may be underlying issues related to hormone levels in CFS patients that are influenced by vitamin C therapy. However, we also noted potential side effects with the sole use of the new vitamin C infusion. A careful balance between the different infusion approaches is crucial for achieving the best outcomes in CFS management.
Overall, while we observed some promising responses to vitamin C treatments, more research is necessary to fully understand its effectiveness and to optimize treatment strategies for those suffering from chronic fatigue syndrome.
However, our findings highlight four key issues. First, it is still debated whether these treatments should continue on a maintenance basis when no acute symptoms are present. Some evidence suggests their ongoing use is crucial for halting an evolving bacterial colony in patients with immune deficiencies.
Second, we noted an emerging problem with drug-resistant bacteria, which posed challenges in treatment effectiveness. New antibiotics, like kanamycin, showed promise in addressing this resistance and improving pneumonia symptoms.
Third, we observed a decline in bone marrow function in one patient over a nine-year observation period, indicating potential fibrosis similar to that seen in lung tissue.
Lastly, we encountered a case where a female patient developed breast cancer during treatment, raising concerns about the risks of prolonged autoimmune conditions in older adults. Interestingly, dehydroepiandrosterone appeared to support hepatic recovery during cancer chemotherapy, suggesting complex interactions between treatments and patient responses.
Overall, while vitamin C plays a role in the treatment approach, the complexities of chronic fatigue syndrome and interstitial pneumonia present challenges that require further investigation.
References
- Mikirova N, Hunninghake R. Effect of high dose vitamin C on Epstein-Barr viral infection. Med Sci Monit. 2014;20:725. doi:10.12659/MSM.890423
- Kodama M, Kodama T. Four problems with the clinical control of interstitial pneumonia, or chronic fatigue syndrome, using the megadose vitamin C infusion system with dehydroepiandrosterone-cortisol annex. In Vivo. 2006;20:285.
- Kodama M, Kodama T. The clinical course of interstitial pneumonia alias chronic fatigue syndrome under the control of megadose vitamin C infusion system with dehydroepiandrosterone-cortisol annex. Int J Mol Med. 2005;15:109.
- Kodama M, Kodama T, Murakami M. The value of the dehydroepiandrosterone-annexed vitamin C infusion treatment in the clinical control of chronic fatigue syndrome (CFS). II. Characterization of CFS patients with special reference to their response to a new vitamin C infusion treatment. In Vivo. 1996;10:585.
- Kodama M, Kodama T, Murakami M. The value of the dehydroepiandrosterone-annexed vitamin C infusion treatment in the clinical control of chronic fatigue syndrome (CFS). I. A Pilot study of the new vitamin C infusion treatment with a volunteer CFS patient. In Vivo. 1996;10:575.
